Helmi M Lubis, Dr, Sp.A(K) Ridwan M Daulay, Dr, SpA(K) Wisman Dr, Sp.A
Bronchiolitis
Bronchioles inflammation
Clinical syndromes:
fast breathing, breathing difficulties, retractions, wheezing, poor feeding, , cough, irritability, (very young) apnoe. Predominantly < 2 years of age (2 6 months) Difficult to differentiate with pneumonia
Pathology
Necrosis of the resp. epithelium
Destruction of ciliated epithelial cells
Bronchiolitis
Peribronchial infiltration with lymphocites & neutrophils Sub mucosal edematous No destruction of collagen, muscle, or elastic tissue
Pathophysiology
Edema + accumulation of mucous & cellular debris narrow of peripheral airway partially / totally occluded over distention / atelectasis
Bronchiolitis
Etiology
Predominantly RSV (Respiratory Syncytial Virus) Other viruses : rhinovirus, adenovirus, influenza virus,
Severity
Bronchiolitis
Diagnosis
Etiological diagnosis
Microbiologic examination
Clinical diagnosis
Signs and symptoms Age Resource of infection epidemic of RSV
Bronchiolitis
Bronchiolitis
Radiologic examination
diffuse hyperinflation
flat diaphragm, Intercostal space > retrosternal space >
peribronchial infiltrates / thickening patchy atelectasis segmental collapse pleural effusion (rare) Laboratory finding
Respiratory rate : Arterial saturation
pCO2
Bronchiolitis
Laboratory finding
Microbiologic examination WBC : 5000 24.000 cells/mm3, predominantly PMN &
HCO3-
PaCO2 40
24 mEq/l
7.4
pH
Differential Diagnosis
Asthma Pneumonia
Acute Bronchitis
Congestive Heart Failure Pulmonary Edema Obstruction in the lower respiratory tract
Bronchiolitis
Management
Mild treated at home Moderate / severe disease hospitalization
oxygen intra venous fluid drip (antibiotics) detect & treat possible complication prevent the spread of inf. Controversial : bronchodilator corticosteroid antiviral antibiotic
support :
2 Agonist
Flores and Horwitz, 1997 Meta-analysis of RCT inhaled 2 Agonist Sample : 3 inpatient & 5 outpatient studies Treatment : nebulized albuterol Outcome : clinical score, satO2, LOS Result : unavailable evidence of 2 Agonist efficacy
Corticosteroid
Garrison et al, 2000 Databases (Medline, Embase, Cochrane)
Treatment : Prednison equivalent 0,6-6,3 mg/kg. Total : 3,0 18,9 mg/kg Outcome : LOS, duration of symptoms (DOS), clinical scores Result : LOS and DOS clinical score
Corticosteroid
Clinical score : Wheezing SatO2 Accessory muscle use RR Conclusion : Benefits depend on severity and initiation of treatment
Bronchiolitis
3 or 4 d Cilia after 3 or 4 d Improved clinical findings : in 3-4 days Improved radiological features: in 9 days
Prognosis
23% infant asthma at 3 years,
Control 1% asthma OR : 28; 90% CI 4-1235 (Garrison et al. 2000 after Sigurs et al. 1995)
Bronchiolitis